sucrose and Carcinoma, Non-Small Cell Lung

sucrose has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Bai, H; Chang, G; Du, X; Duan, J; Li, L; Li, W; Wan, R; Wang, J; Wang, M; Wang, Y; Wang, Z; Yu, R; Zhang, X; Zhu, Y	1
Alessi, JV; Awad, MM; Cheng, ML; Cherniack, AD; Felt, KD; Glass, C; Gupta, H; Li, YY; Lindsay, J; Nishino, M; Ricciuti, B; Rodig, SJ; Sharma, B; Sholl, LM; Spurr, LF	1

Other Studies

2 other study(ies) available for sucrose and Carcinoma, Non-Small Cell Lung

Article	Year
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer, 2022, Volume: 13, Issue:21 Topics: Carcinoma, Non-Small-Cell Lung; DNA Helicases; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Nuclear Proteins; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Retrospective Studies; Sucrose; Transcription Factors	2022
SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:7 Topics: Carcinoma, Non-Small-Cell Lung; DNA Helicases; Genomics; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Nuclear Proteins; Sucrose; Transcription Factors	2021

Article

Year

Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer.

Thoracic cancer, 2022, Volume: 13, Issue:21

Topics: Carcinoma, Non-Small-Cell Lung; DNA Helicases; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Nuclear Proteins; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Retrospective Studies; Sucrose; Transcription Factors

2022

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:7

Topics: Carcinoma, Non-Small-Cell Lung; DNA Helicases; Genomics; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Nuclear Proteins; Sucrose; Transcription Factors

2021